Carlos María Galmarini
Carlos María Galmarini publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer-related Molecular Pathways, Synthesis and Biological Activity and Microtubule and mitosis dynamics.
- World rank
- #1,440,212 of 7,710,434 ranked researchers
- Rank in Spain
- #29,775 of 204,306
- Works
- 317
- Citations
- 10k
- Citations per work
- 32.3
What does Carlos María Galmarini research?
Carlos María Galmarini's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (28%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else12539.3%
- Life Sciences10432.9%
- Health Sciences8827.8%
- Medicine8827.8%
- 1Molecular Biology21% of their works
- 2Oncology17% of their works
- 3Cancer Research8% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Cell Biology4% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Carlos María Galmarini's research?
The keywords of their largest research topics: Cancer Therapy, Prognostic Factors, Chemotherapy, Cell Cycle, p53, Ecteinascidin, Tetrahydroisoquinoline and Cell Division.
- Nucleotide Metabolism
- DNA
- Chronic Lymphocytic Leukemia
- Soft Tissue Sarcoma
- EGFR Mutations
- Cell Division
- Ecteinascidin
- Cell Cycle
- Prognostic Factors
- Cancer Therapy
- Chemotherapy
- p53
- Tetrahydroisoquinoline
- Microtubules
- Osteosarcoma
- Targeted Therapy
- Genomic Aberrations
- Enzyme Regulation
- Topoisomerases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer Therapy422 topics
- Prognostic Factors312 topics
- Chemotherapy302 topics
- Cell Cycle221 topic
- p53221 topic
- Ecteinascidin211 topic
- Tetrahydroisoquinoline211 topic
- Cell Division201 topic
- Microtubules201 topic
- EGFR Mutations161 topic
- Osteosarcoma161 topic
- Soft Tissue Sarcoma161 topic
- Targeted Therapy161 topic
- Chronic Lymphocytic Leukemia151 topic
- Genomic Aberrations151 topic
- DNA141 topic
- Enzyme Regulation141 topic
- Nucleotide Metabolism141 topic
- Topoisomerases141 topic
Where does Carlos María Galmarini work?
Carlos María Galmarini's main affiliation in the publication record is PharmaMar (Spain), Spain.
How many publications and citations does Carlos María Galmarini have?
OpenAlex counts 317 works and 10,224 citations for Carlos María Galmarini, an h-index of 46, ranking #1,440,212 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlos María Galmarini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.